Эстония - эстонский - Ravimiamet

intervet international b.v. - inaktiveeritud rotaviirus+veiste koroonaviirus, inaktiveeritud+escherichia coli, inaktiveeritud - süsteemulsioon - 40ml 1tk; 100ml 1tk; 10ml 1tk; 2ml 10tk

Эстония - эстонский - Ravimiamet

vetviva richter gmbh - butorfanool - süstelahus - 10mg 1ml 10ml 5tk; 10mg 1ml 10ml 1tk

Эстония - эстонский - Ravimiamet

gedeon richter plc. - dekvaliin - vaginaaltablett - 10mg 6tk

Эстония - эстонский - Ravimiamet

gedeon richter plc. - amlodipiin - tablett - 5mg 30tk

Эстония - эстонский - Ravimiamet

vetviva richter gmbh - asaperoon - süstelahus - 40mg 1ml 50ml 1tk

Эстония - эстонский - Ravimiamet

gedeon richter plc. - östradiool - vaginaaltablett - 10mcg 24tk; 10mcg 18tk

Эстония - эстонский - Ravimiamet

gedeon richter plc. - lidokaiin - intrauteriingeel - 42mg 1ml 10ml 1tk

Европейский союз - эстонский - EMA (European Medicines Agency)

kite pharma eu b.v. - autologous peripheral blood t cells cd4 and cd8 selected and cd3 and cd28 activated transduced with retroviral vector expressing anti-cd19 cd28/cd3-zeta chimeric antigen receptor and cultured (brexucabtagene autoleucel) - lümfoom, mantle-cell - antineoplastilised ained - mantle cell lymphomatecartus is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl) after two or more lines of systemic therapy including a bruton’s tyrosine kinase (btk) inhibitor. acute lymphoblastic leukaemiatecartus is indicated for the treatment of adult patients 26 years of age and above with relapsed or refractory b-cell precursor acute lymphoblastic leukaemia (all).

Эстония - эстонский - Ravimiamet

gedeon richter plc. - sitagliptiin - õhukese polümeerikattega tablett - 100mg 60tk; 100mg 90tk; 100mg 56tk; 100mg 84tk; 100mg 30tk; 100mg 28tk

Эстония - эстонский - Ravimiamet

gedeon richter plc. - levonorgestreel - suus dispergeeruv tablett - 1,5mg 1tk